CRYOLIFE
Cryolife (跨奧) is a Hong Kong-founded, privately held cord blood bank (est. 1996) that cryopreserves umbilical cord blood and cord tissue stem cells for expectant parents in Hong Kong and Macau via 18–28 year subscription plans, supported by 18 consecutive years of AABB certification.
- Company typePrivate
- Founded1996
- HeadquartersSha Tin, Hong Kong SAR China
- Headcount101–250
- GTM typeB2C
- OfferingServices
CRYOLIFE firmographics
Firmographics- Name
- CRYOLIFE
- Legal name
- Cryolife
- Website
- https://cryolife.com.hk
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Cryolife (跨奧) is a Hong Kong-founded, privately held cord blood bank (est. 1996) that cryopreserves umbilical cord blood and cord tissue stem cells for expectant parents in Hong Kong and Macau via 18–28 year subscription plans, supported by 18 consecutive years of AABB certification.
- Ownership category
- akta.pro rank
CRYOLIFE industry classification
Industry- Product category
- Cord Blood Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Public Warehousing & Storage (4220)
- akta.pro primary industry
- Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
Keywords
Where CRYOLIFE is headquartered
LocationHeadquarters
- HQ city
- Sha Tin
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Offices1 record
Markets served
CRYOLIFE business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Cord Blood Storage Subscription: Cryolife generates recurring revenue through annual and multi-year subscription plans for cord blood and cord tissue storage services. Plans range from 18 to 28 years of storage, with options for annual payment or deferred payment arrangements. Revenue is recognized over the storage period with upfront payments common.
- Cord Tissue Storage: Additional storage service for umbilical cord tissue, which contains mesenchymal stem cells (MSCs) that can differentiate into bone, cartilage, muscle, nerve and other cell types. Often bundled with cord blood storage in combined plans.
- Value-Added Services: Additional paid services including HLA (Human Leukocyte Antigen) testing and Metakodomo testing services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Cord Blood Storage Plan (18-28 Year Plan) |
| Subscription | Annual | Cord Blood + Cord Tissue Storage Plan (18-28 Year Plan) |
| One time/ perpetual license | Multi-year contract | Safe Migration Program |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
CRYOLIFE product offering
Product offeringCore offering
Cryolife operates a cord blood and umbilical cord tissue cryopreservation bank offering long-term storage (18-28 years) of hematopoietic and mesenchymal stem cells for expectant parents in Hong Kong and Macau. Its core subscriptions cover cord blood storage and combined cord blood plus cord tissue storage, supplemented by optional HLA tissue-typing and Metakodomo inherited metabolic disease genetic testing. The service encompasses collection kit provision at birth, processing, ultra-low temperature MVE-based storage, and twice-yearly quality assurance reporting on stem cell viability.
Product overview
Cryolife (跨奧) is a cord blood and cord tissue cryopreservation bank operating as a unified service platform. The company offers two core storage products: Cord Blood Storage and Cord Blood + Cord Tissue Storage, both with 18-28 year plan options. Optional add-on services include HLA Testing and Metakodomo genetic testing. The products are offered through a single service platform with multiple registration and enrollment options, and a migration program for samples from other banks. Founded in 1996 as Hong Kong's first cord blood bank, the company has maintained continuous AABB certification for 18 years while storing over 40,000 cord blood samples.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Storage Plan (臍帶血儲存計劃) Cryopreservation service for umbilical cord blood stem cells (hematopoietic stem cells) with 18-28 year storage plans. The service covers collection, processing, and ultra-low temperature storage to preserve stem cells for treatment of blood diseases (leukemia, lymphoma, aplastic anemia), immune disorders, and hereditary metabolic conditions. Targeted at expectant parents in Hong Kong and Macau as biological insurance for the newborn's future health.
- Cord Blood + Cord Tissue Storage Plan (臍血+臍帶儲存計劃) Combined cryopreservation of cord blood hematopoietic stem cells and umbilical cord tissue-derived mesenchymal stem cells (MSCs) with 18-28 year storage plans. MSCs can differentiate into bone, cartilage, muscle, nerve and other cell types, enabling regenerative medicine applications for degenerative diseases. Marketed as 'double protection' for the child's future health. Targeted at expectant parents seeking maximum coverage.
- HLA Testing (增值自選測試) Human Leukocyte Antigen (HLA) tissue-typing testing service that determines tissue compatibility for potential future transplants. Offered as an add-on to cord blood storage customers.
- Metakodomo (遺傳代謝病基因檢測) Genetic testing service for inherited metabolic diseases, offered as an optional add-on to Cryolife's cord blood storage services for parents who want additional screening information.
- Safe Migration Program One-time HK$5,000 service for transferring existing cord blood samples stored at other banks into Cryolife's MVE cryogenic storage facility. Targeted at parents who want to consolidate their child's stored sample with a provider that holds AABB certification.
Quantifiable outcome
- AABB certification held for 18 consecutive years
- +3 more outcomes
Companies that use CRYOLIFE
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
CRYOLIFE technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CRYOLIFE partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Stem Cell Research Institutions and UniversitiesminorCryolife collaborates with local and international stem cell research institutions and top universities for scientific research and clinical applications. However, specific partner names are not disclosed on the website.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
CRYOLIFE competitors and assessment
Company assessmentDirect peers
- Cryo-Cell International: Cryo-Cell is a US-based, publicly-traded cord blood bank offering cord blood and cord tissue storage with a multi-year subscription model; it is one of the largest and oldest private cord blood banks globally and operates a comparable AABB-accredited cryopreservation business.
- Cells4Life: Cells4Life is a UK-based private cord blood and tissue bank offering long-duration cryopreservation storage services with multiple plan tiers, operating an internationally comparable subscription-based cord blood banking model to Cryolife.
- HealthBaby: HealthBaby is a Hong Kong-based private cord blood bank offering cord blood and cord tissue cryopreservation services to expectant parents, directly competing with Cryolife in the same HK/Macau market with a similar subscription-based storage model.
- Smart Cells International: Smart Cells is a UK-founded private cord blood stem cell bank offering storage services globally with an international enrollment model; it competes directly with Cryolife in the cross-border private cord blood banking market segment.
- Biovault Family: Biovault Family is a UK-based private cord blood and tissue bank offering long-duration subscription storage plans, comparable to Cryolife's 18-28 year subscription model and consumer-focused biological insurance positioning.
- StemCyte: StemCyte is a US-based cord blood bank with both private family storage and public banking operations, providing comparable AABB-accredited cryopreservation services and HLA testing capabilities to those offered by Cryolife.
- Cord Blood Registry (CBR): CBR, operated by CooperSurgical, is one of the largest US private cord blood banks with a subscription storage model for cord blood and cord tissue, directly comparable in service offering, AABB accreditation, and customer acquisition approach to Cryolife.
- ViaCord: ViaCord is a US-based private cord blood bank offering cord blood and cord tissue storage with multi-year subscription plans; it competes in the same consumer-facing biological insurance category with similar cryopreservation and HLA testing capabilities as Cryolife.
Regional players
- China Cord Blood Corporation (Cell Tech Group): China Cord Blood Corporation operates one of the largest cord blood banking networks in mainland China; while geographically distinct from Hong Kong, it is the most relevant regional player for Cryolife given proximity, shared Chinese-speaking customer base, and overlapping service offerings.
- Cryoviva: Cryoviva is an Asia-focused cord blood banking company with operations in Singapore, Thailand, India, and Hong Kong; it overlaps with Cryolife in Hong Kong/Macau-adjacent Asian markets and offers comparable cord blood storage services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CRYOLIFE financial estimates
Financial estimateRevenue estimate
Valuation estimate
CRYOLIFE leadership team
Management profileNumber of profiles
CRYOLIFE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CRYOLIFE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CRYOLIFE
What does CRYOLIFE do?
Cryolife operates a cord blood and umbilical cord tissue cryopreservation bank offering long-term storage (18-28 years) of hematopoietic and mesenchymal stem cells for expectant parents in Hong Kong and Macau. Its core subscriptions cover cord blood storage and combined cord blood plus cord tissue storage, supplemented by optional HLA tissue-typing and Metakodomo inherited metabolic disease genetic testing. The service encompasses collection kit provision at birth, processing, ultra-low temperature MVE-based storage, and twice-yearly quality assurance reporting on stem cell viability.
Is CRYOLIFE a public or private company?
CRYOLIFE is a private company. It is classified as unknown and is currently operating.
When was CRYOLIFE founded?
CRYOLIFE was founded in 1996. It employs 101 to 250 people.
Where is CRYOLIFE based?
CRYOLIFE is headquartered in Sha Tin, Hong Kong SAR China, in the Asia region.
How does CRYOLIFE make money?
Three revenue lines are on record. Cord Blood Storage Subscription is the primary driver. The others are cord Tissue Storage and value-Added Services.
Who are CRYOLIFE's main competitors?
Direct peers on record are Cryo-Cell International, Cells4Life, HealthBaby, Smart Cells International, Biovault Family, StemCyte, Cord Blood Registry (CBR) and ViaCord. Regional players are China Cord Blood Corporation (Cell Tech Group) and Cryoviva.
Does CRYOLIFE have an API?
No public API is recorded for CRYOLIFE.
What industry is CRYOLIFE in?
CRYOLIFE's product category is Cord Blood Banking Services. Its primary akta.pro industry code is HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991 and its SIC code is 2836.